The sales are routine post-grant liquidity events with no informational content. Monitor VKTX for upcoming clinical trial catalysts (obesity drug pipeline) which are the primary price drivers, not insider trading patterns at this scale.
VKTX drugs
VKTX drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jul 30 $33.11entry
- T+1 · 4mo ago −4.14%α −4.84% · $31.74
- T+5 · 3mo ago +0.57%α −3.05% · $33.30
- T+20 · 3mo ago +2.27%α −1.70% · $33.86
- T+60 · 25d ago −26.31%α −28.77% · $24.40
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
VKTX CFO and COO sold a combined $1.32M in open-market sales on July 29, 2026, at ~$33.47/share, following non-cash stock grants on July 28. The sales represent ~0.03% of VKTX's $3.9B market cap, trivial in proportion. Both executives sold on the same day after receiving identical restricted stock grants, consistent with routine tax- or liquidity-driven sales following vesting, not a bearish signal.
Key Financial Metrics
Key Facts
- CFO Greg Zante sold 21,217 shares for ~$710K on July 29, 2026 at $33.47
- COO Marianna Mancini sold 18,217 shares for ~$610K on July 29, 2026 at $33.47
- Both executives received identical grants of 31,667 shares each on July 28, 2026 (non-cash, $0 value)
- Total open-market sales of $1.32M represent ~0.03% of VKTX's $3.9B market cap
- Sales occurred one day after non-cash stock grants, consistent with tax withholding or diversification
Financial Impact
Total insider sales of $1.32M, representing 0.03% of market cap, immaterial
Risk Factors
- Insider sales could accelerate if stock appreciates further, but current volume is negligible
- No bearish signal from this cluster, the risk is missing the real catalyst (pipeline data) by over-interpreting routine sales
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-VKTX-1785370031485 |
Track record
13 reports on VKTX
5 of 5 bullish or bearish reports moved the stock their way by T+1. Best: +31.38% at T+20 after the Sep 24, 2026 report. 5 of 5 went positive at some point.
Filters
- Nov 5, 202611d ago SC 13G/A Neutral 3/10 Entry $25.79 to $26.84 Now $26.80 +3.92% ▲ +4.07% +3.76% vs SPY
- Oct 28, 202619d ago 8-K Neutral 5/10 Entry $26.86 to $27.28 Now $26.80 −0.22% ▲ +1.56% +3.34% vs SPY
- Oct 23, 202624d ago Institutional Cluster Bearish 4/10 Entry $24.40 to $24.21 Now $26.80 −9.84% ▲ +0.78% +1.49% vs SPY
- Oct 21, 202626d ago Press Release Neutral 1/10 Entry $25.83 to $24.40 Now $26.80 +3.76% ▼ −5.54% −5.01% vs SPY
- Sep 28, 20267w ago 8-K Mixed 6/10 Entry $31.81 to $32.60 Now $26.80 −15.75% ▲ +2.48% +2.69% vs SPY
- Sep 24, 20267w ago 424B5 Bearish 5/10 Entry $35.56 to $33.03 Now $26.80 +24.63% ▲ +7.11% +6.37% vs SPY
- Sep 24, 20267w ago 424B5 Bearish 6/10 Entry $35.56 to $33.03 Now $26.80 +24.63% ▲ +7.11% +6.37% vs SPY
- Sep 23, 20267w ago 424B5 Neutral 4/10 Entry $36.75 to $35.56 Now $26.80 −27.07% ▼ −3.24% −3.78% vs SPY
- Sep 23, 20267w ago 424B5 Bearish 6/10 Entry $36.75 to $35.56 Now $26.80 +27.07% ▲ +3.24% +3.78% vs SPY
- Sep 22, 20267w ago 8-K Bullish 7/10 Entry $40.85 to $41.65 Now $26.80 −34.39% ▲ +1.96% +2.68% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers